Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03898986 · ClinicalTrials.gov registry record · Phase 1
The Effects of Attenuated Versus Inactivated Flu Vaccine in Twin Sets
A Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT03898986: Completed Phase 1 study, sponsored by Stanford University.
NCT03898986 is a Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03898986, a Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
This is one project of a larger ongoing study related to the immune system's response to the flu virus. This study is designed to investigate the immune response to the live attenuated influenza vaccine (LAIV) vs. the Inactivated Influenza Vaccine (IIV) in identical and fraternal twins.
Interventions
- BIOLOGICAL Inactivated Influenza Vaccine (IIV4)
- BIOLOGICAL Live attenuated influenza vaccine (LAIV4)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2019-10-08 |
| Est. Completion | 2023-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03898986
The ClinicalTrials.gov registry entry for NCT03898986 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Inactivated Influenza Vaccine (IIV4) is the first listed.
NCT03898986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03898986 about?
NCT03898986 is a clinical study titled "The Effects of Attenuated Versus Inactivated Flu Vaccine in Twin Sets". This is one project of a larger ongoing study related to the immune system's response to the flu virus. This study is designed to investigate the immune response to the live attenuated influenza vaccine (LAIV) vs. the Inactivated Influenza Vaccine (IIV) in identical and fraternal twins.
What is the current status of trial NCT03898986?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2019-10-08. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT03898986?
The interventions under investigation include: Inactivated Influenza Vaccine (IIV4) (BIOLOGICAL), Live attenuated influenza vaccine (LAIV4) (BIOLOGICAL).
Who is sponsoring clinical trial NCT03898986?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.